Arete Wealth Advisors »

Bioxcel Therapeutics shares owned by Arete Wealth Advisors

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Arete Wealth Advisors from 13F filings

Historical chart of Arete Wealth Advisors investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Arete Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $25k 41k 0.62
2023-12-31 $322k 109k 2.95

More positions owned by Arete Wealth Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Walt Disney Company (DIS)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Vaneck Etf Trust Ig Floating Rate (FLTR)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Value Etf (EFV)
Spdr Gold Tr Gold Shs (GLD)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Amazon (AMZN)

View all positions for Arete Wealth Advisors

Top funds holding Bioxcel Therapeutics

Armistice Capital
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Wells Fargo & Company
Renaissance Technologies
State Street Corporation
Morgan Stanley
Goldman Sachs Group
Bank of America Corporation
Citadel Advisors
Jane Street
Susquehanna International
Bnp Paribas Arbitrage, Snc

View all funds holding Bioxcel Therapeutics